⚠️ Research Use Only. This article documents publicly available information about a discussed protocol for informational purposes only.
Who Is Clavicular?
Clavicular is an influential figure in the online looksmaxxing and body optimisation community, whose multi-compound research stack gained mainstream attention via a widely-shared New York Times article. The article specifically documented compound choices, rationale, and protocol structure — making it one of the most detailed public records of a contemporary research peptide protocol.
The Documented Protocol: 7 Core Compounds
The original documented stack includes seven foundational compounds across five pathways:
NYT Interview Additions (Compounds 8–9 in Ascension)
The New York Times article attributed two additional compounds directly to Clavicular: L-Glutathione 600mg (antioxidant cytoprotection during concurrent compound use) and Anavar/Oxandrolone 25mg (glucocorticoid receptor downregulation and cortisol management during caloric deficit).
Community Extensions: ClavTides & Apollo Protocol
Compound
Protocol
Mechanism
BPC-157 10mg
ClavTides
NO pathway + EGF/FGF/VEGF + FAK-paxillin cascades → tissue repair
GHRH analog → pulsatile GH amplification without desensitisation
Why Each Compound Was Chosen
Retatrutide over Tirzepatide: Triple GIP/GLP-1/GCGR agonism adds direct fat oxidation via glucagon receptor — phase 2 data shows ~24% weight loss vs ~20.9% for tirzepatide.
Melanotan II: UV-free melanogenesis via MC1R with ~33-hour half-life. MC4R appetite modulation complements Retatrutide’s GLP-1-driven suppression for additive effects.
L-Glutathione: In protocols involving concurrent androgens and metabolic agents, oxidative load and hepatic processing increase. Glutathione’s Phase II conjugation and antioxidant functions provide the cytoprotective safety layer.
The Venus Protocol is the women’s health companion: 10 compounds, no androgens, no steroids. View Venus Protocol →
Frequently Asked Questions
What is the Clavicular looksmaxxing protocol?
The Clavicular protocol is a multi-compound research stack documented in a widely-shared New York Times article. Clavicular is a prominent figure in the looksmaxxing community who publicly discussed their compound protocol in detail. The confirmed compounds from the NYT interview include Retatrutide, Melanotan II, HGH, IGF-1 LR3, GHK-Cu, NAD+, Testosterone Cypionate, L-Glutathione, and Anavar. Community extensions (ClavTides, Apollo) added BPC-157, TB-500, and CJC-1295 No DAC.
Where was Clavicular’s protocol documented?
Clavicular’s protocol was detailed in a New York Times article that profiled the looksmaxxing subculture, specifically attributing compound choices to Clavicular. Additional compound detail appears in forum posts on Looksmax.org. Community researchers subsequently extended the documented protocol — adding BPC-157/TB-500 (ClavTides) and CJC-1295 No DAC (Apollo protocol).
What is ClavTides?
ClavTides is a community extension of the Clavicular protocol adding a tissue repair layer: BPC-157 (Body Protection Compound) paired with TB-500 (Thymosin Beta-4 fragment). Both compounds are included as compounds 9 and 10 in the QSC Ascension Stack.
Is there a women’s version of the Clavicular protocol?
Yes — the Venus Protocol is the women’s health companion stack. 10 compounds, no androgens, no steroids. Covers metabolic (Retatrutide), skin/collagen (GHK-Cu + Glutathione), anti-aging (NAD+ + Epithalon), tissue repair (BPC-157 + TB-500), GH/sleep (CJC-1295 + Ipamorelin), and sexual wellness (PT-141). Available at qscpeptide.com.
